We designed a new material that could target and neutralize brain-damaging molecules in mice, improving their cognitive recovery and offering a potential new treatment for people. The primary stage of ...

In a new study on mice, an experimental antibody treatment reduced the lingering after-effects of head injuries.

Researchers at Mass General Brigham found that a nasal spray delivering anti-CD3 (Foralumab) reduces neuroinflammation, limits central nervous system damage and improves behavioral outcomes in mice ...

Could football players with a concussion one day be treated with a quick spray up their nose? That could be a possibility one ...

A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer’s disease is underway ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Aaron Priester, Missouri University of Science and Technology (THE CONVERSATION ...

Nasal anti-CD3 spray reduces traumatic brain injury in mice, a potential breakthrough for TBI treatment. Read now.

A new study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI).

New Delhi: A nasal spray being developed to target brain inflammation can also prove effective in treating traumatic brain injury (TBI) -- a leading cause of death and disability, according to a study ...

Lastly, we injected the thiol polymers into mice with traumatic brain injury. Brain scans showed that our polymer not only successfully concentrated in the damaged area of the brain but also ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) While much of the physical brain damage occurs instantly – called the primary ...